Miłosz Mandryk

Miłosz Mandryk

Auto-generated profile, based on publicly available information

Miłosz Mandryk

4th Military Clinical Hospital, ul. Rudolfa Weigla 5, 50-981 Wrocław, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JPJakub Plizga
Jakub Plizga
AJArkadiusz Jaworski
Arkadiusz Jaworski
FGFilip Jan Grajnert
Filip Jan Grajnert
AGAgnieszka Gluszczyk
Agnieszka Gluszczyk
ASAlicja Surma
Alicja Surma
NHNazar Holdun
Nazar Holdun
High-Intensity Interval Training (HIIT) has become a prominent exercise modality known for its efficiency and effectiveness in improving various health outcomes. This review critically examines the positive and negative health aspects of HIIT, focusing on its impact on cardiovascular health, metabolic function, weight management, psychological well-being, and life expectancy. Evidence suggests that HIIT significantly enhances cardiovascular health by improving VO2 max, reducing blood pressure, and enhancing endothelial function. Metabolically, HIIT improves insulin sensitivity, glucose metabolism, and lipid profiles, while effectively reducing visceral fat and enhancing mitochondrial function. In terms of weight management, HIIT promotes fat loss and muscle maintenance, contributing to favorable body composition. Psychologically, HIIT has been shown to reduce symptoms of anxiety and depression, improve cognitive function, and enhance overall mental health. It has also a positive effect on chronic pain conditions. Emerging studies indicate that HIIT may reduce mortality risk and extend life expectancy by improving cardiovascular and metabolic health. Despite these benefits, HIIT also presents risks such as a higher incidence of musculoskeletal injuries, potential adverse cardiac events in high-risk individuals, and the risk of overtraining and burnout. Special populations, including older adults, children, adolescents, and individuals with chronic conditions, can benefit from HIIT, but modifications and precautions are necessary to ensure safety and effectiveness. The review underscores the importance of individualized HIIT program design, thorough assessment, and continuous monitoring to maximize benefits while minimizing risks. Future research should focus on long-term effects, optimal protocols for diverse populations, and personalized HIIT approaches to enhance safety and efficacy.

13 September 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JCJakub Cecot
Jakub Cecot
KZKonrad Zarzecki
Konrad Zarzecki
MMMiłosz Mandryk
Miłosz Mandryk
PJPaweł Jerczyński
Paweł Jerczyński
DDDominika Dzik
Dominika Dzik
MPMałgorzata Piasta
Małgorzata Piasta
Obesity, affecting One in eight people, poses significant health risks, including an increased risk of cognitive impairment and dementia. This article is exploring the complex and multifaceted relationship between obesity and cognitive function, highlighting several mechanisms that may contribute to cognitive decline in obese individuals. Research reveals that obesity in middle age is associated with a higher risk of cognitive decline, while in older adults, it might provide some protection against rapid cognitive deterioration. In adolescents, obesity is linked to lower scores on cognitive tests, indicating damaging effects on cognitive abilities from an early age. Key mechanisms discussed include neuroinflammation, mitochondrial dysfunction, and insulin resistance. Neuroinflammation involves elevated levels of pro-inflammatory cytokines leading to increased blood-brain barrier permeability and potential neuronal damage. Mitochondrial dysfunction in obesity results in impaired neuronal function due to disrupted mitochondrial processes. Insulin resistance, a common feature of obesity, affects brain regions critical for memory and executive functions. Additionally, the impact of weight loss on cognitive function is examined, with evidence suggesting that weight reduction through bariatric surgery, lifestyle interventions, or pharmacological treatments can improve cognitive abilities. However, further research is needed to establish definitive causal relationships and to understand the underlying biological changes.

1 January 2024 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
JCJakub Cecot
Jakub Cecot
KZKonrad Zarzecki
Konrad Zarzecki
MMMiłosz Mandryk
Miłosz Mandryk
Cecot J, et al. J Clin Neurol. 2024 Aug;20:e64. https://doi.org/10.3988/jcn.2024.0288

3 September 2024 in Archiv Euromedica
Verified
Journal Article
Closed access
JPJakub Plizga
Jakub Plizga
AGAgnieszka Głuszczyk
Agnieszka Głuszczyk
ASAlicja Surma
Alicja Surma
JCJakub Cecot
Jakub Cecot
APAgnieszka Parfianowicz
Agnieszka Parfianowicz
AJArkadiusz Jaworski
Arkadiusz Jaworski
Purpose of Research: This study aims to evaluate the impact of various artificial sweeteners on gut microbiota and their potential health implications. Research Materials and Methods: A literature review was conducted using PubMed, focusing on keywords such as gut microbiota, artificial sweeteners, non-nutritive sweeteners, and intestinal microbiota. The review includes descriptions of sweeteners like aspartame, sucralose, saccharin, acesulfame K, and stevia, as well as their metabolism and effects on the human body. Primary Results: Artificial sweeteners can disrupt gut microbiota balance, reducing beneficial bacteria like Bifidobacterium and Lactobacillus while increasing pathogenic bacteria such as Clostridium difficile and E. coli. Clinical trials show mixed results, with some studies indicating significant changes in microbiota composition and diversity, while others show no substantial effects. Differences influence the variability in study outcomes in participants' initial microbiota composition, lifestyle, and dietary habits. Conclusions: Artificial sweeteners impact gut microbiota, but the extent and nature of these effects still need to be fully understood. Further standardized, long-term research is required to clarify these effects and determine whether the benefits of artificial sweeteners outweigh potential risks to gut health. Advanced research methods like metagenomics and next-generation sequencing will enhance our understanding of artificial sweeteners' interaction with gut microbiota, aiding in comprehensive health assessments.

2 August 2024 in Quality in Sport
Verified
Journal Article
Open access
APAgnieszka Parfianowicz
Agnieszka Parfianowicz
ASAlicja Surma
Alicja Surma
AJArkadiusz Jaworski
Arkadiusz Jaworski
FGFilip Jan Grajnert
Filip Jan Grajnert
JPJakub Plizga
Jakub Plizga
NHNazar Holdun
Nazar Holdun
Surgeries and procedures in otolaryngology require close collaboration between anesthesiologists and ENT specialists, especially for operations involving the larynx and airways, which pose challenges for maintaining airway patency and visibility. Choosing the type of anesthesia, whether general or local, is crucial. This study examines the benefits and drawbacks of both types of anesthesia in tonsillectomy and adenoidectomy, tympanostomy and myringotomy, and flexible endoscopic biopsy of the pharynx and larynx. A review of current guidelines, systematic reviews and relevant clinical cohort studies was conducted. The findings highlight several advantages of local anesthesia, including shorter operation times, reduced hospital stays, lower costs, decreased use of analgesics, and improved patient comfort.

3 September 2024 in Archiv Euromedica
Verified
Journal Article
Closed access
JCJakub Cecot
Jakub Cecot
KZKonrad Zarzecki
Konrad Zarzecki
MMMilosz Mandryk
Milosz Mandryk
APAgnieszka Parfianowicz
Agnieszka Parfianowicz
JPJakub Plizga
Jakub Plizga
FGFilip Jan Grajnert
Filip Jan Grajnert
Aims: This study aims to evaluate the efficacy and safety of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, in promoting weight loss in patients with obesity. Methods: A comprehensive literature review was conducted using PubMed and Google Scholar databases for articles published between 2020 and 2024. Keywords included tirzepatide, LY3298176, tirzepatide obesity, tirzepatide side effects, and tirzepatide adverse effects. Studies included were randomized, placebo-controlled, and involved patients with a body mass index (BMI) ≥ 30 kg/m² or ≥ 27 kg/m² with at least one weight-related comorbidity. Results: Analysis covered 5,385 participants from phase 2 and 3 trials, with 3,517 treated with tirzepatide and 1,868 receiving placebo. Tirzepatide demonstrated significant weight reduction across studies: SURMOUNT-1 (15.0%, 19.5%, 20.9% weight loss for 5, 10, 15 mg doses respectively), SURMOUNT-2 (12.8%, 14.7% for 10, 15 mg doses), NASH SYNERGY (10.7%, 13.3%, 15.6% for 5, 10, 15 mg doses), and SURMOUNT-OSA (17.7%, 19.6% for maximum tolerated dose). Adverse effects were mostly gastrointestinal, with nausea, diarrhea, and vomiting being the most common, leading to a discontinuation rate of 4.6%. Conclusions: Tirzepatide demonstrates superior efficacy in weight management compared to existing treatments, with an acceptable safety profile. Its dual agonist action offers a promising therapeutic option for obesity, warranting further research into its long-term benefits and impacts on obesity-related comorbidities.